Christopher LaFarge has more than 20 years of experience in managing and leading life science organizations. He has contributed to the development, testing, and approval of several medical devices as well as ISO 13485 certification for MedicaMetrix. Christopher served as President and CEO, and Chairman of MedicaMetrix, Inc., a medical device manufacturer in urology, and prior to this position, he was President at Pharos Medical, a medical device manufacturer in anesthesiology and patient monitoring.
Mr. LaFarge earned his BA in Biology from Harvard College, an MBA from the Yale School of Management, and an MFS (Environmental Science) from Yale University.
Bach is confident that his experience, knowledge, and education will contribute to bring Bach’s novel drug platform GVT® through clinical trials to FDA approval
If you are interested in investing or increasing your investment with Bach Pharma - reach out to Christopher directly,